Literature DB >> 31880901

E-cadherin, Snail, ZEB-1, DNMT1, DNMT3A and DNMT3B expression in normal and breast cancer tissues.

Shaian Tavakolian1, Hossein Goudarzi, Ebrahim Faghihloo.   

Abstract

OBJECTIVE: Breast cancer is known as one of very important cancers among females, given that a variety of external (i.e., environmental risk factors) and internal factors (i.e., genetics, and epigenetics) are related to the emergence and progression of breast cancer. Among genetic and epigenetic factors, DNA methyltransferase and EMT related genes have critical roles in breast cancer pathogenesis. In the study presented here, we investigated expression of DNA methyltransferases (e.g., DNMT1, DNMT3A and DNMT3B) and EMT related genes (e.g., E-cadherin, Snail, ZEB-1). METHODS AND MATERIALS: Tissue samples were collected from 18 cancer and 24 normal breast tissues. We evaluated the expression levels of DNA methyltransferases and EMT related genes using Quantitative real-time PCR (qRT-PCR).
RESULTS: Our results indicated that the expression levels of ZEB-1, Snail, and DNMT3B were increased in breast cancer subjects in comparison to the control group. On the other hand, there was a significant decrease in E-cadherin expression in breast cancer tissues in comparison to the normal tissues. Moreover, there were no significant changes for DNMT1 and DNMT3A expression in breast cancer tissues when compared to the normal tissues.
CONCLUSION: Taken together, our finding show that up regulation of ZEB-1 and Snail could be associated with down regulation of E-cadherin and results in promotion of cancer cell invasion. Moreover, down regulation of E-cadherin may be related to deterioration of DNMT3B inpatients with breast cancer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31880901     DOI: 10.18388/abp.2019_2808

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  7 in total

Review 1.  DNMT3A and DNMT3B in Breast Tumorigenesis and Potential Therapy.

Authors:  Xiaxia Man; Qi Li; Baogang Wang; He Zhang; Songling Zhang; Ziyi Li
Journal:  Front Cell Dev Biol       Date:  2022-05-10

2.  Pterostilbene leads to DNMT3B-mediated DNA methylation and silencing of OCT1-targeted oncogenes in breast cancer cells.

Authors:  Megan Beetch; Cayla Boycott; Sadaf Harandi-Zadeh; Tony Yang; Benjamin J E Martin; Thomas Dixon-McDougall; Kevin Ren; Allison Gacad; John H Dupuis; Melissa Ullmer; Katarzyna Lubecka; Rickey Y Yada; Carolyn J Brown; LeAnn J Howe; Barbara Stefanska
Journal:  J Nutr Biochem       Date:  2021-07-07       Impact factor: 6.048

3.  Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer.

Authors:  Jianzhao Chen; Lixia Feng; Qinghua Sheng; Lianna Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-13       Impact factor: 2.629

4.  Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach.

Authors:  Yee Kit Tai; Karen Ka Wing Chan; Charlene Hui Hua Fong; Sharanya Ramanan; Jasmine Lye Yee Yap; Jocelyn Naixin Yin; Yun Sheng Yip; Wei Ren Tan; Angele Pei Fern Koh; Nguan Soon Tan; Ching Wan Chan; Ruby Yun Ju Huang; Jing Ze Li; Jürg Fröhlich; Alfredo Franco-Obregón
Journal:  Front Oncol       Date:  2022-01-24       Impact factor: 5.738

5.  DNA methyltransferase 1 inhibits microRNA-497 and elevates GPRC5A expression to promote chemotherapy resistance and metastasis in breast cancer.

Authors:  Yaobang Liu; Zhengyang Bai; Dahai Chai; Yali Gao; Ting Li; Yinling Ma; Jinping Li
Journal:  Cancer Cell Int       Date:  2022-03-07       Impact factor: 5.722

6.  Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration.

Authors:  Rupa Guha; Binbin Yue; Jianping Dong; Aditi Banerjee; Ginette Serrero
Journal:  Breast Cancer Res Treat       Date:  2021-02-22       Impact factor: 4.872

7.  The F-box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin-mediated degradation of Snail.

Authors:  Lijiang Shao; Xuehui Zhang; Qi Yao
Journal:  FEBS Open Bio       Date:  2020-07-26       Impact factor: 2.693

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.